Anti Cardiolipin Igm Genlisa Elisa

COVID-19 Rapid Test Kit IgG + IgM (Colloidal Gold) comes in packs of 40 tests and contains: GCMS manufactures COVID-19 antigen test kit, the GENEDIA W COVID-19 Ag which is listed on the EU common list, also with GMP and ISO certifications. GENEDIA W COVID-19 Ag is unaffected based on the in-silicon analysis of the mutations in the nucleocapsid (N gene) of Omicron viruses. Letter of statement is available upon your request. To get over COVID-19 pandemic, especially the recent Omicron breakout, currently we are doing big promotions for three kinds of COVID-19 Ag kit. All are in stock and available right away. 1. Nasopharyngeal 2. Nasal 3. Saliva Price and Minumum Quantity Price FOB in USD: negotiable 0.8 to 1.8Minimum Order Qty: None Pieces Production Capacity: 3,000,000/monthPackaging: 20 Tests/kit, 30 Kits/box, 12 Boxes/pallet Sample: Available. Sample Cost Born By Supplier Product Model And Origin Brand: GENEDIAModel: 643G-S (Saliva) Seller Code: Genedia w covid 19 agHS Code: 3002.15 Standards: Ce Competitive Advantages Allow wider testing with fast test time (10 minutes) All necessary materials provided / no equipment needed Sensitivity: 93.33%, specificity: 100% Free sample. no moq. price is negotiable. customized packing. Other Details 20 tests / kit 24 months from the date of manufacture 2 ~ 30c(35.6 ~ 86f) available for room temperature deliver In stock. fast delivery. 1 x Instructions for Use Manual 40 x Test Cassettes 1 x Buffer 40 x Dropper

Biosensors is a medical device company known for its innovations in interventional cardiology, particularly in the field of coronary stents. The BioMatrix platform includes a range of drug-eluting stents (DES) designed to be used in the treatment of coronary artery disease. Key features of the BioMatrix stent platform, which may extend to the NeoFlex model if it's a part of the series, may include: Drug-Eluting Stent: The stents in the BioMatrix platform are drug-eluting, meaning they are coated with a medication (such as an anti-restenotic drug) designed to inhibit the regrowth of tissue inside the treated blood vessel. Biodegradable Polymer: Some versions of the BioMatrix stent use a biodegradable polymer to deliver the drug to the target site. The polymer gradually dissolves over time, leaving only the metallic stent behind. Flexible Design: The stents are designed to be flexible, allowing for easier navigation and deployment in the coronary arteries. Thin-Strut Technology: Thin struts can contribute to improved deliverability and conformability of the stent to the vessel wall. Various Sizes: The BioMatrix stent platform typically offers stents in various sizes to accommodate different patient anatomies and lesion characteristics.

the Boston Scientific Promus Elite is a coronary drug-eluting stent system. It is designed for use in patients undergoing percutaneous coronary intervention (PCI) procedures to treat coronary artery disease. Here are some key features and points related to the Boston Scientific Promus Elite coronary stent: Drug-Eluting Stent: The Promus Elite is a drug-eluting stent (DES), meaning it is coated with medication to help prevent the re-narrowing (restenosis) of the treated coronary artery. Drug Coating: The stent typically features a polymer coating containing an anti-proliferative drug. This drug is slowly released over time to inhibit the growth of tissue inside the stent, reducing the risk of restenosis. Cobalt Chromium Alloy: The stent is often made of a cobalt chromium alloy, known for its strength and flexibility. This material allows for a thin stent strut design, which can be beneficial in terms of deliverability and conformability. Delivery System: The stent is delivered to the target area using a catheter-based delivery system. The catheter is guided through the blood vessels to the site of the coronary artery lesion. Radiopaque Markers: Radiopaque markers on the stent aid in proper placement and visualization under X-ray guidance during the procedure.